Q1 2026 Proto Labs Inc Earnings Call Transcript
Proto Labs Inc (PRLB) reported record Q1 2026 revenue of $139.3 million, a 10.4% year-over-year increase, and achieved its highest non-GAAP EPS in over five years, driven by strong CNC machining demand and U.S. market growth. Despite these positive results, European revenue declined, 3D printing revenue was flat, and macroeconomic uncertainties led to conservative full-year guidance. The company also announced achieving AS9100 certification in Europe and ongoing operational changes.
Proto Labs (PRLB) director granted 2,210 deferred stock units
Proto Labs Inc. director Moonhie Chin was granted 2,210 deferred stock units on May 19, 2026, at a price of $0.0000 per share, increasing her direct holdings to 22,306 shares. These units vest fully on the earlier of the first anniversary of the grant date or the company's 2027 Annual Meeting of Shareholders, and must be held until her service on the Board of Directors ends. This transaction was reported in a Form 4 filing and is considered a neutral event for the stock.
Proto Labs (PRLB) director receives 2,210 restricted stock units as equity grant
Proto Labs director Donald G. Krantz was granted 2,210 restricted stock units (RSUs) as an equity award, not a market purchase. These RSUs, valued at $0.00 per share, will vest fully on the earlier of one year from the grant date or the 2027 Annual Meeting of Shareholders. Following this transaction, Krantz directly holds 26,863 shares of Proto Labs common stock.
[Form 4] Proto Labs Inc Insider Trading Activity
Proto Labs Inc. director Sujeet Chand reported an acquisition of 2,210 shares of common stock as deferred stock units with no cash price. These units vest on the earlier of the first anniversary of the grant date or the 2027 Annual Meeting of Shareholders and must be held until Chand's service on the Board ends. Following this transaction, Chand directly holds 26,863 shares of Proto Labs common stock.
Proto Labs Shareholders Approve Directors, Auditor and Compensation
Proto Labs (PRLB) shareholders re-elected all seven director nominees, ratified Ernst & Young as the 2026 independent auditor, and approved executive compensation in an advisory vote. Investors also opted for annual say-on-pay votes and cleared an amendment to the 2022 Long-Term Incentive Plan, reinforcing stability in governance and compensation practices. TipRanks' AI Analyst, Spark, rated PRLB as "Outperform," citing strong financial health and cash generation despite high P/E valuation and market uncertainties in Europe.
Proto Labs shareholders approve director slate and incentive plan amendment
Proto Labs Inc. shareholders approved the election of all seven director nominees and an amendment to the 2022 Long-Term Incentive Plan, increasing available shares by 395,000. The company, which has seen its shares return 72% over the past year, also ratified Ernst & Young LLP as its accounting firm and approved executive compensation. These approvals follow strong financial results, including first-quarter 2026 earnings that surpassed analyst expectations.
Proto Labs shareholders approve director slate and incentive plan amendment
Proto Labs (NYSE: PRLB) shareholders have approved all seven director nominees to serve until the next annual meeting and an amendment to the 2022 Long-Term Incentive Plan, increasing shares available for issuance by 395,000. These decisions were made during the company's Annual Meeting, following strong financial performance including a 72% return over the past year and a perfect Piotroski Score of 9.
Proto Labs Inc Annual Shareholders Meeting Transcript
This article provides the transcript of the Proto Labs Inc Annual Shareholders Meeting held on May 19, 2026, at 01:30 PM GMT. The meeting was called to order by Suresh Krishna, President, Chief Executive Officer, and Director of ProtoLabs, who welcomed attendees and introduced the company's directors. The content also lists various past earnings call transcripts and conference appearances for Proto Labs Inc.
Precision Trading with Proto Labs Inc. (PRLB) Risk Zones
This article from Stock Traders Daily provides a detailed analysis of Proto Labs Inc. (PRLB), indicating strong sentiment across all time horizons but also elevated downside risk. It outlines distinct trading strategies (Position, Momentum Breakout, Risk Hedging) with specific entry, target, and stop-loss zones based on AI-generated signals. The analysis also includes multi-timeframe support and resistance levels for precision trading.
Proto Labs COO Michael Kenison sells $1.6m in company stock
Proto Labs COO Michael Kenison sold company stock worth $1.6 million on May 11 and 12, 2026, through a pre-arranged 10b5-1 trading plan. The sales occurred as Proto Labs shares traded near their 52-week high, having gained 72% over the past year and appearing overvalued according to InvestingPro analysis. Concurrently, Kenison acquired 14,960 shares by exercising employee stock options, bringing his direct holdings to 18,683 shares.
Proto Labs (PRLB) COO sells 23,463 shares under 10b5-1 plan
Proto Labs Inc.'s Chief Operations Officer, Michael R. Kenison, sold a total of 23,463 shares of company common stock between May 11-12, 2026, under a pre-arranged Rule 10b5-1 trading plan. During the same period, he also exercised employee stock options for 14,960 shares at various exercise prices. Following these transactions, Kenison directly holds 18,683 Proto Labs shares.
Earnings call transcript: Protolabs beats Q1 2026 expectations, stock dips
Protolabs (PRLB) announced strong first-quarter 2026 results, surpassing analyst expectations with an EPS of $0.54 and record revenue of $139.3 million. Despite these positive figures, the stock experienced a slight pre-market decline before recovering. The company's performance was driven by robust U.S. operations, particularly in CNC machining, and strategic improvements in Europe.
Michael Kenison Sells 200 Shares of Proto Labs (NYSE:PRLB) Stock
Proto Labs insider Michael Kenison sold 200 shares of the company's stock at $70.00 each, totaling $14,000, under a pre-arranged Rule 10b5-1 plan. This transaction occurred after Proto Labs reported strong Q1 earnings, beating analyst estimates for both EPS and revenue, with revenue increasing 10.4% year over year. The stock has a consensus analyst rating of "Moderate Buy" with an average target price of $53.33, despite trading near its 52-week high of $70.00.
Proto Labs (NYSE: PRLB) COO executes 10b5-1 option exercises and small share sale
Proto Labs Inc's Chief Operations Officer, Michael R. Kenison, sold 200 shares of common stock at $70.00 per share and exercised stock options to acquire 200 shares at strike prices of $33.52 and $33.84, all under a pre-arranged 10b5-1 trading plan. Following these transactions on May 7, 2026, Kenison directly holds 27,186 Common Stock shares and retains substantial employee stock options. This activity is considered routine, involving equity compensation and a pre-planned sale, demonstrating ongoing long-term equity exposure.
Proto Labs COO Michael Kenison sells $14,000 in company stock
Michael R. Kenison, COO of Proto Labs Inc (NASDAQ:PRLB), sold 200 shares of company stock for $14,000, aligning with a pre-arranged trading plan. This sale occurred shortly after Kenison acquired 200 shares through employee stock options. The transactions follow a significant 70% surge in Proto Labs' shares over the past year and a strong Q1 2026 financial performance.
Protolabs Strengthens Executive Leadership Team with Appointment of Bernardo Parlange as Chief Commercial Officer
Protolabs has appointed Bernardo Parlange as Chief Commercial Officer, effective May 18, 2026, to lead its global commercial strategy, including sales, marketing, and customer success. Parlange brings over 20 years of experience in B2B industrial commercial leadership. The company also announced the planned retirement of Chief Operations Officer, Mike Kenison, effective July 1, 2026, after two decades of service.
Protolabs Strengthens Executive Leadership Team with Appointment of Bernardo Parlange as Chief Commercial Officer
Protolabs has announced the appointment of Bernardo Parlange as its new Chief Commercial Officer, strengthening its executive leadership team. This insight was delivered by Quantisnow, a real-time market data and news platform. The article also provides recent analyst ratings and related SEC filings for Proto Labs Inc. (PRLB).
Proto Labs (NYSE: PRLB) adds Chief Commercial Officer as COO plans retirement
Proto Labs (NYSE: PRLB) has announced executive leadership changes, including the retirement of Chief Operations Officer Michael R. Kenison on July 1, 2026. The company also appointed Bernardo Parlange as its first Chief Commercial Officer, effective May 18, 2026. Parlange will be responsible for leading global commercial strategy to drive revenue growth and enhance customer relationships.
Protolabs Appoints Agnes Semington as Chief Human Resources Officer
Protolabs has announced the appointment of Agnes Semington as its new Chief Human Resources Officer. This news was released via Quantisnow, a real-time market data and news platform that aggregates market intelligence for retail investors. The company, Proto Labs Inc. (PRLB), operates in the Industrials sector.
Does Record Q1 Results And 2026 Growth Outlook Change The Bull Case For Proto Labs (PRLB)?
Proto Labs (PRLB) reported record Q1 2026 results with increased revenue and net income, alongside a positive 2026 revenue growth outlook. This performance strengthens the bull case for the company, driven by its digital manufacturing platform and strong CNC machining demand. While European weakness and transformation costs remain potential risks, the positive Q2 guidance suggests sustained momentum, reinforcing investor confidence in its ongoing transformation and AI investments.
Protolabs Sets Conference Call to Discuss First Quarter 2026 Financial Results
Protolabs (PRLB) has scheduled a conference call to discuss its first-quarter 2026 financial results. The announcement highlights recent analyst ratings, including updates from Craig Hallum and Cantor Fitzgerald, and lists recent insider transactions and SEC filings from the company. This information is sourced from Quantisnow, a real-time market data platform.
PRLB SEC Filings - Proto Labs Inc 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for investors and traders to access Proto Labs (PRLB) SEC filings, including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms. It highlights the availability of AI-powered summaries for these documents, which condense key information like revenue trends and risk factors. The article also details recent filings, such as an insider purchase by the CEO and a quarterly earnings report, along with Proto Labs' updated market rankings and stock data.
Proto Labs : Protolabs Investor Presentation – May 2026
Protolabs' May 2026 Investor Presentation highlights the company's position as an undisputed leader in digital manufacturing, serving over 48,000 customers and 85% of Fortune 500 companies in target industries. The presentation emphasizes its hybrid "Factory x Network" model, which offers industry-best lead times and comprehensive capabilities, driving significant customer retention and financial performance. Protolabs reported $533M in revenue for FY2025 with a 6.4% YoY change and maintains a strong financial profile with zero debt and a 12% revenue CAGR since its 2012 IPO.
Proto Labs (NYSE:PRLB) Stock Forecast & Analyst Predictions
Proto Labs (NYSE:PRLB) is forecasted to grow earnings and revenue by 23% and 6.5% annually, respectively, with EPS expected to grow by 22.6%. The company recently reported record Q1 2026 revenue and adjusted EPS, exceeding analyst expectations, driven by CNC machining and increased customer engagement. Despite risks like historical earnings declines, Proto Labs is pursuing strategic initiatives including executive changes, innovative platform launches like ProDesk, and share repurchases to drive future growth and enhance operational efficiency.
Proto Labs Inc 1Q 2026: Revenue $139.3M, EPS $0.33— 10-Q Summary
Proto Labs Inc (PRLB) reported its Q1 2026 financial results, with revenue reaching $139.3M and diluted EPS of $0.33, indicating significant year-over-year growth in both sales and profitability. The company's revenue growth was primarily driven by higher CNC machining and injection molding sales, despite a decrease in the number of customer contacts. Management also undertook restructuring efforts to streamline operations and reallocate resources towards technology and automation.
Proto Labs, Inc. (NYSE:PRLB) Q1 2026 Earnings Call Transcript
Proto Labs, Inc. (NYSE:PRLB) reported
Proto Labs Reports Record Q1 2026 Earnings with Strong Growth
Proto Labs announced record Q1 2026 revenue of $139.3 million, marking a 10.4% year-over-year increase and their fourth consecutive quarter of double-digit growth. The company also improved its non-GAAP gross margin to 46.2% due to better cost control and operational efficiency. Management projects a positive outlook with anticipated full-year revenue growth of 6% to 8% for 2026.
Proto Labs (PRLB) Reports Strong Q1 2026 Revenue Growth and Posi
Proto Labs Inc (PRLB) reported a strong Q1 2026 with record revenue of $139.3 million, a 10.4% increase year-over-year, largely driven by its CNC machining services. Despite a high P/E ratio of 74.06 and recent insider selling, the company's GF Score™ of 73/100 indicates solid financial health and profitability. Investors are advised to consider the mixed signals of strong growth and high valuation when evaluating PRLB.
Proto Labs (NYSE:PRLB) Stock Price Down 10.7% - What's Next?
Proto Labs (NYSE:PRLB) saw its stock price drop 10.7% on Friday, closing at $57.90 with significantly reduced trading volume. This occurred despite the company beating Q1 earnings expectations with $0.54 EPS and revenue of $139.34 million, and issuing Q2 guidance of $0.500–$0.580 per share. The stock holds a "Moderate Buy" consensus rating from analysts, but institutional ownership stands at approximately 84.5% following recent stake increases.
Proto Labs (NYSE: PRLB) Q1 2026 revenue rises 10% as profit more than doubles
Proto Labs (NYSE: PRLB) reported a strong first quarter for 2026, with revenue increasing by 10.4% to $139.3 million, largely driven by its CNC machining segment and growth in both U.S. and European operations. The company's net income more than doubled to $8.1 million, and diluted EPS rose to $0.33, benefiting from improved gross margins and a lower effective tax rate. Proto Labs maintains a robust balance sheet with $124.0 million in cash and cash equivalents, and it continues to focus on strategic pillars like enhancing customer experience, accelerating innovation, and expanding production.
Proto Labs: Q1 Earnings Snapshot
Proto Labs Inc. (PRLB) reported a first-quarter profit of $8.1 million, or 33 cents per share. Adjusted earnings were 54 cents per share, with total revenue reaching $139.3 million. The company forecasts its per-share earnings for the current quarter ending in June to be between 50 cents and 58 cents.
Proto Labs (NYSE: PRLB) delivers record Q1 2026 revenue and boosts non-GAAP EPS
Proto Labs (NYSE: PRLB) reported record Q1 2026 revenue of $139.3 million, marking a 10.4% increase year-over-year, driven by strong growth in CNC machining. The company also saw significant improvements in profitability, with GAAP diluted EPS doubling to $0.33 and non-GAAP diluted EPS rising to $0.54. Protolabs provided a positive outlook for full-year 2026, expecting revenue growth between 6% and 8%, and strong guidance for Q2 2026.
Protolabs Reports Financial Results for the First Quarter of 2026
Protolabs (NYSE: PRLB) announced strong financial results for the first quarter of 2026, achieving a record revenue of $139.3 million, marking a 10.4% increase year-over-year. The company reported GAAP earnings per diluted share of $0.33 and non-GAAP earnings per diluted share of $0.54, driven by double-digit revenue growth and improved profitability. Protolabs also provided optimistic guidance for the second quarter and the full fiscal year 2026, anticipating continued revenue growth and strong non-GAAP diluted net income per share.
Proto Labs: Q1 Earnings Snapshot
Proto Labs Inc. reported a Q1 profit of $8.1 million, or 33 cents per share, with adjusted earnings of 54 cents per share. The custom parts manufacturer recorded revenues of $139.3 million for the period. For the upcoming quarter ending in June, Proto Labs anticipates earnings per share to be between 50 and 58 cents.
Proto Labs: Q1 Earnings Snapshot
Proto Labs Inc. reported a Q1 profit of $8.1 million, or 33 cents per share, which adjusted to 54 cents per share. The custom parts manufacturer achieved revenue of $139.3 million during the period. For the upcoming quarter ending in June, Proto Labs anticipates earnings per share to be between 50 and 58 cents.
Proto Labs Q1 Earnings Exceed Expectations
Proto Labs reported strong Q1 results, with non-GAAP EPS of $0.54 and revenue of $139.3 million, both exceeding analyst expectations. The company also saw a significant 20.4% year-over-year increase in revenue per customer contact and maintains an optimistic outlook, projecting 6% to 8% revenue growth for fiscal year 2026.
Vanguard holds 5.1% of Proto Labs (NASDAQ: PRLB) in Schedule 13G
Vanguard Capital Management reported a 5.1% beneficial ownership stake in Proto Labs (NASDAQ: PRLB), totaling 1,213,755 shares of common stock as of March 31, 2026. The Schedule 13G filing indicates Vanguard has sole voting power over 174,014 shares and sole dispositive power over all 1,213,755 shares. This filing is a regulatory disclosure for large ownership stakes acquired for investment purposes.
Proto Labs earnings in focus as transformation year kicks off
Proto Labs Inc. is set to report first-quarter earnings, with investors closely watching for signs of progress in its 2026 transformation plan, including the adoption of its new AI-enabled manufacturing platform, ProDesk. Analysts have a consensus price target of $71.67, implying a 15% upside, with a focus on continuing momentum in CNC machining, strategic shifts toward higher-value manufacturing, and updates on acquisition plans. The company's prior quarter saw strong performance, beating consensus on both earnings and revenue, leading to a significant stock surge.
Proto Labs, Inc. Experiences Revision in Its Stock Evaluation Amid Strong Market Performance
Proto Labs, Inc. has recently adjusted its stock valuation, with its current price at $63.68, and has seen a remarkable 79.94% return over the past year, significantly outperforming the S&P 500. The company exhibits strong operational efficiency with a P/E ratio of 60 and a return on equity of 3.26%. Compared to its peers in the specialty chemicals industry, Proto Labs shows a more favorable valuation profile.
Vanguard holds 1.55M Proto Labs (NASDAQ: PRLB) shares — 6.51% stake
Vanguard Portfolio Management has reported a beneficial ownership of 1,548,595 shares of Proto Labs (NASDAQ: PRLB) common stock, representing a 6.51% stake as of March 31, 2026. This Schedule 13G filing indicates a passive investment, with Vanguard exercising sole dispositive power over all shares and sole voting power over 10,065 shares. The holdings include securities managed for Vanguard funds and client accounts.
Proto Labs earnings in focus as transformation year kicks off
Proto Labs (NYSE: PRLB) is set to release its first-quarter earnings, with analysts expecting 36 cents per share on $132.7 million in revenue. Investors will be focused on the early adoption of its new AI-enabled ProDesk platform, continued momentum in CNC machining, and strategic shifts towards higher-value injection molding and acquisitions as part of its 2026 transformation plan. The company's January earnings beat expectations, causing a 19% stock surge.
Proto Labs, Inc. (NYSE:PRLB) Given Consensus Recommendation of "Moderate Buy" by Analysts
Analysts have issued a "Moderate Buy" consensus rating for Proto Labs, Inc. (NYSE:PRLB), with an average 12-month price target of $53.33, despite the stock recently trading around $64.47. The company surpassed quarterly earnings estimates, reporting $0.44 EPS versus $0.35 expected, and revenue of $136.49 million, up 12.1% year-over-year. Insider selling by Director Michael R. Kenison and significant institutional ownership (84.54%) are also highlighted.
Proto Labs (PRLB) Expected to Announce Earnings on Friday
Proto Labs (NYSE:PRLB) is scheduled to announce its Q1 2026 earnings before the market open on Friday, May 1st, with analysts projecting an EPS of $0.40 and revenue of $135.31 million. The company's previous quarter exceeded expectations, reporting $0.44 EPS and $136.49 million in revenue. The stock currently trades near $64, and institutional investors own approximately 84.5% of the shares.
Proto Labs (NYSE:PRLB) Stock Price Passes Above 200 Day Moving Average - Should You Sell?
Proto Labs (NYSE:PRLB) stock price has risen above its 200-day moving average, reaching $64.0150. The company recently reported strong quarterly earnings, surpassing analyst estimates, and analysts have a "Moderate Buy" rating for the stock with an average target price of $53.33. Insider selling and institutional investor activity also provide a detailed picture of current sentiment around the stock.
Proto Labs and Rocket Lab Poised to Lead US Manufacturing Resurgence
Proto Labs and Rocket Lab are positioned to benefit significantly from the anticipated resurgence in US manufacturing, driven by reshoring efforts and increasing factory output, especially in AI-related sectors. Proto Labs demonstrated strong performance in late 2025 with rising earnings and revenue in its CNC machining segment, though it faces challenges with European revenue and tariffs. Both companies, along with material producers like Hecla Mining, are expected to thrive as domestic production increases, with Proto Labs aiming for an ambitious $1 billion in annual revenue.
Does ProDesk's AI Push Make Proto Labs (PRLB) Indispensable to Regulated Aerospace Manufacturing?
Proto Labs recently launched ProDesk, an upgraded e-commerce platform with AI-powered quoting and design-for-manufacturability analysis, targeting regulated aerospace manufacturing. This initiative aims to deepen AI integration in its digital workflow, potentially making Proto Labs a more crucial partner for complex industries. Investors should consider if this move will translate into higher revenue per customer and improved operating leverage, particularly given the company's existing projections of significant revenue and earnings growth by 2029.
Proto Labs (NYSE:PRLB) Share Price Crosses Above Two Hundred Day Moving Average - Time to Sell?
Proto Labs (NYSE:PRLB) recently surpassed its 200-day moving average, reaching $63.41, signaling bullish technical momentum despite a lower consensus target price from analysts. The company reported strong Q4 2025 earnings, beating estimates, but an insider recently sold shares. Institutional ownership is high at 84.54%, with several funds increasing their stakes.
A Look At Proto Labs (PRLB) Valuation After The ProDesk E Commerce Platform Launch
Proto Labs has launched ProDesk, a new e-commerce platform with AI-powered features for aerospace customers, following a period of strong share performance. While the company's "narrative fair value" suggests it is undervalued, its high P/E ratio compared to industry and peers indicates significant market expectation already priced in. Investors are prompted to consider whether the ProDesk launch and future earnings warrant this premium.
Is Proto Labs (PRLB) Using AI to Redefine Its Aerospace Competitive Moat?
Proto Labs has launched ProDesk, an AI-enabled e-commerce platform aimed at accelerating aerospace product development. This move, coupled with their engagement with the Space Foundation, signifies a strategic focus on the aerospace sector to leverage AI for improved manufacturing processes and client engagement. The success of this initiative hinges on its ability to increase revenue per customer and enhance operating leverage, offsetting the risks of increasing investment costs.
PRLB Price Today: PROTO LABS, INC. Stock Price, Quote & Chart
This article provides current stock price information for PROTO LABS, INC. (PRLB), trading at $62.82. It details key market data such as market cap, open, high, low, and volume, along with its strong price performance over the past month and year. The article also includes information on how to buy PRLB stock on MEXC and provides an overview of Proto Labs Inc. as an on-demand manufacturer.
